Paul Dykewicz

Connect with Paul Dykewicz

Paul Dykewicz

Paul Dykewicz, www.pauldykewicz.com, is an accomplished, award-winning journalist who has written for Dow Jones, the Wall Street JournalInvestor’s Business DailyUSA Today, the Journal of Commerce, Crain Communications, Seeking Alpha, Guru Focus and other publications and websites. Paul can be followed on Twitter @PaulDykewicz, and is the editor and a columnist at StockInvestor.com and DividendInvestor.com. He also serves as editorial director of Eagle Financial Publications in Washington, D.C. In that role, he edits monthly investment newsletters, time-sensitive trading alerts, free weekly e-letters and other reports.

Previously, Paul served as business editor and a columnist at Baltimore’s Daily Record newspaper and as a reporter at the Baltimore Business Journal. Plus, Paul is the author of an inspirational book, “Holy Smokes! Golden Guidance from Notre Dame’s Championship Chaplain,” with a foreword by former national championship-winning football coach Lou Holtz. The uplifting book is endorsed by Joe Montana, Joe Theismann, Ara Parseghian, “Rocket” Ismail, Reggie Brooks, Dick Vitale and many other sports figures. To buy signed and specially dedicated copies, call 202-677-4457.

In addition, Paul occasionally serves as a commentator about investing, economics, business news, politics and motivational guidance. The latter is based on the wit and wisdom featured in his book about Notre Dame’s legendary sports chaplain, Rev. James Riehle, who aided four national championship football teams that triumphed despite facing powerful opponents.

Paul also earned a master’s degree in business administration with a concentration on finance at Baltimore’s Johns Hopkins University, where he was elected to two terms as president of the Carey Business School’s Finance Club.

In 2017, Paul served as a guest lecturer at the Michigan State University School of Journalism, where he earlier earned a master’s degree and was inducted into the Kappa Tau Alpha honor society for academic excellence and scholarship in journalism and mass communication. He also worked as a graduate assistant at the school and as a communications intern at the National Cancer Institute. His master’s degree thesis focused on how best to reach various demographic groups with potentially life-saving cancer information in Washington, D.C. While in graduate school, he served as an intern in the Capitol Bureau of WDIV-TV, the NBC station in Detroit, and at a news radio station in Michigan’s capital of Lansing.

Before earning his two graduate degrees, Paul received a bachelor’s degree from the University of Michigan in Ann Arbor, where he focused on political science, business and economics. He also served as a reporter and an editor at a student newspaper, as well as the host of a public radio program about how to prepare for careers in fields such as health care and engineering.

Paul has won many journalism awards, including several from the Maryland-Delaware-DC Press Association, an APEX National Editorial award from the Newsletter Publishers Association, a “Journalist of the Year” Award from Phillips Business Information (now Access Intelligence) and others. Avocations include running, fitness, music and the arts. Paul also is active in his church and has been recognized by the Muscular Dystrophy Association and Catholic Charities.

Latest posts by Paul Dykewicz

Contrarian Dividend Investing Offers the Key to Profiting From Gold and Other Undervalued Assets

Paul Dykewicz

28 Jul 2021

Contrarian dividend investing offers ways to profit from gold and other undervalued assets that currently are out of favor, according [...] READ MORE ≫

Nine Dividend-Paying Oil Investments to Purchase as the Energy Market Heats Up

Paul Dykewicz

23 Jul 2021

Nine dividend-paying oil investments to purchase as the economy heats up and energy prices climb belong to an industry that [...] READ MORE ≫

Two Dividend-Paying Generic Pharmaceutical Stocks to Buy for Income

Paul Dykewicz

16 Jul 2021

Two dividend paying generic pharmaceutical stocks to buy for income highlight companies arguably near the top of that sector. The [...] READ MORE ≫

Four Dividend-paying Biopharmaceutical Investments to Buy Use Genetics to Produce Growth and Income

Paul Dykewicz

08 Jul 2021

Four dividend-paying biopharmaceutical investments to buy use genetics to produce growth and income amid the pandemic. The four biopharmaceutical investments [...] READ MORE ≫

Three Dividend-paying Biopharmaceutical Investments to Purchase During the Pandemic

Paul Dykewicz

30 Jun 2021

Three dividend-paying biopharmaceutical investments to purchase during the pandemic provide investors with a chance to profit from two exchange-traded funds [...] READ MORE ≫

Eight Dividend-paying Pharmaceutical Investments to Purchase

Paul Dykewicz

23 Jun 2021

Eight dividend-paying pharmaceutical investments to purchase in pursuit of profits and income feature established industry behemoths and two exchanged-traded funds (ETFs). [...] READ MORE ≫

3 Dividend-paying Cell Tower Stocks to Purchase for the Budding 5G Rollout

Paul Dykewicz

18 Jun 2021

Three dividend-paying cell tower stocks to purchase for the budding rollout of 5G growth opportunities give investors ways to tap [...] READ MORE ≫

Five Dividend-paying 5G Stocks to Buy

Paul Dykewicz

11 Jun 2021

Five dividend-paying 5G stocks to buy are expected to ride a growing technology wave that should boost companies that provide [...] READ MORE ≫

7 Dividend-Paying Metals Investments to Purchase as Protection Against Inflation

Paul Dykewicz

04 Jun 2021

Seven dividend-paying metals investments to purchase as protection against inflation amid an ongoing economic recovery should gain a boost from rising [...] READ MORE ≫

Six Dividend-paying Mining Stocks to Purchase as Inflation Concerns Mount

Paul Dykewicz

28 May 2021

Six mining stocks to purchase as inflation concerns mount during the economic recovery are benefiting from rising prices for cooper, [...] READ MORE ≫

Share Paul Dykewicz's Bio page:

X
Search Dividend Investor